A shadow market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to message these profiles privately for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers promote the drug there before directing customers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, physicians and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of unknown origin.
Several experts stated the popularity for the experimental drug could be linked to the increasing price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, legal action or prison.
Service Response and Material Elimination
According to the social media company, the service has removed problematic content and banned associated hashtags and search suggestions. The company stated it was committed to keeping the service safe and investing in enhancing compliance measures.
Online Marketplace Activities
Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of members, populated with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at residence.
After minutes of joining one group, a seller posted WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.
Product Information and Costs
Within these communities, messages show black plastic parcels with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram stated it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they can’t verify. Although the science behind retatrutide is sound, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to potentially serious medical dangers”.
